Profusa (PFSA) Cash from Financing Activities (2023 - 2026)
Profusa (PFSA) reported Cash from Financing Activities of $28000.0 for Q1 2026, down 92.33% on a YoY basis from $365000.0 in Q1 2025, and down 99.43% quarter-over-quarter from $4.9 million in Q4 2025.
Profusa (PFSA) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Profusa has reported Cash from Financing Activities for 4 years, with the latest figure at $28000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 92.33% year-over-year to $28000.0; the trailing twelve-month figure through Mar 2026 stood at $19.5 million (up 310.2% YoY), and the FY2025 full-year result was $19.8 million, up 838.2% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $28000.0, down from $4.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $20.9 million in Q3 2025, with the low at -$184.8 million in Q1 2023.
- Historically, Cash from Financing Activities has averaged -$12.4 million across 4 years, with a median of $343426.0 in 2023.
- The largest YoY upside for Cash from Financing Activities was 1597.58% in 2025 against a maximum downside of 2025.11% in 2025.
- Profusa's Cash from Financing Activities stood at $408800.0 in 2023, then dropped by 29.31% to $289000.0 in 2024, then soared by 1597.58% to $4.9 million in 2025, then slumped by 99.43% to $28000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $28000.0 (Q1 2026), $4.9 million (Q4 2025), and $20.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Profusa | 1.37 Mn | 1.37 Mn | - | 28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,000.00 |
| Mar 31, 2026 | 28,000.00 |
| Dec 31, 2025 | 4.91 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 20.94 Mn |
| Sep 30, 2025 | 20.94 Mn |
| Jun 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | -6.37 Mn |
| Mar 31, 2025 | 365,000.00 |
| Mar 31, 2025 | 365,000.00 |
| Dec 31, 2024 | 289,000.00 |
| Dec 31, 2024 | 289,000.00 |
| Sep 30, 2024 | 3.77 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | 330,796.00 |
| Jun 30, 2024 | 330,796.00 |
| Mar 31, 2024 | -2.28 Mn |
| Mar 31, 2024 | -2.28 Mn |
| Dec 31, 2023 | 408,800.00 |
| Dec 31, 2023 | 408,800.00 |